KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationCost of RevenueEBIATGross ProfitLong-Term Debt IssuancesLong-Term Debt RepaymentsOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - NetReceivables - OtherShares OutstandingShares OutstandingShares RepurchasedShort-Term Debt issuances
Ratios

Thermo Fisher Scientific (TMO) Other Gross PP&E Adjustments (2016 - 2025)

Thermo Fisher Scientific filings provide 17 years of Other Gross PP&E Adjustments readings, the most recent being $18.4 billion for Q4 2025.

  • On a quarterly basis, Other Gross PP&E Adjustments rose 14.45% to $18.4 billion in Q4 2025 year-over-year; TTM through Dec 2025 was $18.4 billion, a 14.45% increase, with the full-year FY2025 number at $18.4 billion, up 14.45% from a year prior.
  • Other Gross PP&E Adjustments hit $18.4 billion in Q4 2025 for Thermo Fisher Scientific, up from $16.1 billion in the prior quarter.
  • In the past five years, Other Gross PP&E Adjustments ranged from a high of $18.4 billion in Q4 2025 to a low of $12.6 billion in Q4 2021.
  • Median Other Gross PP&E Adjustments over the past 5 years was $15.5 billion (2023), compared with a mean of $15.4 billion.
  • Biggest five-year swings in Other Gross PP&E Adjustments: skyrocketed 31.49% in 2021 and later increased 3.45% in 2024.
  • Thermo Fisher Scientific's Other Gross PP&E Adjustments stood at $12.6 billion in 2021, then increased by 13.31% to $14.3 billion in 2022, then grew by 8.8% to $15.5 billion in 2023, then rose by 3.45% to $16.1 billion in 2024, then rose by 14.45% to $18.4 billion in 2025.
  • The last three reported values for Other Gross PP&E Adjustments were $18.4 billion (Q4 2025), $16.1 billion (Q4 2024), and $15.5 billion (Q4 2023) per Business Quant data.